We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
American Resources Corp
AREC
$293M
| $147K | 0.02% |
101,445
+27,613
| +37% | +$49.2K |
|
|
PR
1152
Permian Resources
PR
$16.9B
| $147K | 0.02% |
24,579
-54,776
| -69% | -$438K |
|
1153
Hope Bancorp
HOPE
$1.79B
| $146K | 0.02% |
+10,566
| New | +$154K |
|
|
TGI
1154
DELISTED
Triumph Group
TGI
| $145K | 0.02% |
+10,895
| New | +$206K |
|
|
AVDX
1155
DELISTED
AvidXchange
AVDX
| $144K | 0.02% |
+23,523
| New | +$187K |
|
|
CAN
1156
Canaan Creative
CAN
$159M
| $144K | 0.02% |
+44,652
| New | +$169K |
|
|
CLSD
1157
DELISTED
Clearside Biomedical
CLSD
| $144K | 0.02% |
6,540
+1,322
| +25% | +$32.1K |
|
|
IMDX
1158
Insight Molecular Diagnostics
IMDX
$156M
| $144K | 0.02% |
8,012
+112
| +1% | +$2.55K |
|
|
ONL
1159
Orion Office REIT
ONL
$160M
| $144K | 0.02% |
+13,159
| New | +$170K |
|
|
PMT
1160
PennyMac Mortgage Investment
PMT
$842M
| $144K | 0.02% |
+10,417
| New | +$159K |
|
|
OLPX
1161
DELISTED
Olaplex Holdings
OLPX
| $143K | 0.02% |
10,162
-15,798
| -61% | -$234K |
|
1162
Uranium Energy
UEC
$5.57B
| $143K | 0.02% |
+46,567
| New | +$194K |
|
1163
LegalZoom.com
LZ
$988M
| $141K | 0.02% |
12,811
-16,317
| -56% | -$216K |
|
|
SAFE
1164
Safehold
SAFE
$1.15B
| $141K | 0.02% |
2,111
-3,174
| -60% | -$267K |
|
|
TRHC
1165
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $141K | 0.02% |
+55,040
| New | +$206K |
|
|
BDN
1166
Brandywine Realty Trust
BDN
$554M
| $140K | 0.02% |
14,492
-51,665
| -78% | -$583K |
|
1167
Edgewise Therapeutics
EWTX
$4.68B
| $138K | 0.02% |
+17,312
| New | +$131K |
|
1168
FNB Corp
FNB
$6.75B
| $138K | 0.02% |
12,708
-45,443
| -78% | -$531K |
|
1169
Owlet
OWLT
$160M
| $138K | 0.02% |
+5,810
| New | +$287K |
|
1170
Purple Innovation
PRPL
$41.7M
| $137K | 0.02% |
+1,787
| New | +$208K |
|
1171
Heritage Insurance Holdings
HRTG
$991M
| $134K | 0.02% |
+50,916
| New | +$217K |
|
1172
Super League Enterprise
SLE
$4.65M
| $134K | 0.02% |
14
-5
| -26% | -$65K |
|
1173
Mercer International
MERC
$39.8M
| $133K | 0.02% |
+10,109
| New | +$150K |
|
1174
TechnipFMC
FTI
$27.3B
| $132K | 0.02% |
19,563
-263,662
| -93% | -$2.01M |
|
|
AHRT
1175
AH Realty Trust
AHRT
$517M
| $131K | 0.02% |
10,185
-21,751
| -68% | -$296K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.